204 related articles for article (PubMed ID: 10350529)
1. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia.
Takahashi K; Pieper AA; Croul SE; Zhang J; Snyder SH; Greenberg JH
Brain Res; 1999 May; 829(1-2):46-54. PubMed ID: 10350529
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats.
Takahashi K; Greenberg JH; Jackson P; Maclin K; Zhang J
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1137-42. PubMed ID: 9390644
[TBL] [Abstract][Full Text] [Related]
3. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
Ding Y; Zhou Y; Lai Q; Li J; Gordon V; Diaz FG
Brain Res; 2001 Oct; 915(2):210-7. PubMed ID: 11595210
[TBL] [Abstract][Full Text] [Related]
4. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
5. The effect of reperfusion on neuroprotection using an inhibitor of poly(ADP-ribose) polymerase.
Takahashi K; Greenberg JH
Neuroreport; 1999 Jul; 10(10):2017-22. PubMed ID: 10424667
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation.
Lo EH; Bosque-Hamilton P; Meng W
Stroke; 1998 Apr; 29(4):830-6. PubMed ID: 9550519
[TBL] [Abstract][Full Text] [Related]
7. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.
Nakajima H; Kakui N; Ohkuma K; Ishikawa M; Hasegawa T
J Pharmacol Exp Ther; 2005 Feb; 312(2):472-81. PubMed ID: 15466246
[TBL] [Abstract][Full Text] [Related]
8. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
Tokime T; Nozaki K; Sugino T; Kikuchi H; Hashimoto N; Ueda K
J Cereb Blood Flow Metab; 1998 Sep; 18(9):991-7. PubMed ID: 9740102
[TBL] [Abstract][Full Text] [Related]
9. Poly (ADP-ribose) polymerase inhibitor reduces heart ischaemia/reperfusion injury via inflammation and Akt signalling in rats.
Song ZF; Chen DY; DU B; Ji XP
Chin Med J (Engl); 2013; 126(10):1913-7. PubMed ID: 23673109
[TBL] [Abstract][Full Text] [Related]
10. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
11. Involvement of independent mechanism upon poly(ADP-ribose) polymerase (PARP) activation in methylmercury cytotoxicity in rat cerebellar granule cell culture.
Sakaue M; Mori N; Okazaki M; Ishii M; Inagaki Y; Iino Y; Miyahara K; Yamamoto M; Kumagai T; Hara S; Yamamoto M; Arishima K
J Neurosci Res; 2008 Nov; 86(15):3427-34. PubMed ID: 18627028
[TBL] [Abstract][Full Text] [Related]
12. [Poly (ADP-ribose) polymerase inhibition attenuates ischemia/reperfusion induced myocardial injury in rat via reducing myocardial nuclear factor κB activity].
Song ZF; DU B; Ji XP
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):997-1002. PubMed ID: 23363712
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
Singh N; Sharma G; Singh N; Hanif K
Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia.
Egi Y; Matsuura S; Maruyama T; Fujio M; Yuki S; Akira T
Brain Res; 2011 May; 1389():169-76. PubMed ID: 21420942
[TBL] [Abstract][Full Text] [Related]
16. The neuroprotective effect of cerebral poly(ADP-ribose)polymerase inhibition in a rat model of global ischemia.
Plaschke K; Kopitz J; Weigand MA; Martin E; Bardenheuer HJ
Neurosci Lett; 2000 Apr; 284(1-2):109-12. PubMed ID: 10771174
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
18. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
[TBL] [Abstract][Full Text] [Related]
19. Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors.
Giovannelli L; Cozzi A; Guarnieri I; Dolara P; Moroni F
J Cereb Blood Flow Metab; 2002 Jun; 22(6):697-704. PubMed ID: 12045668
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
